›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:Labcorp® Plasma Focus™
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
LabCorpType:
Laboratory Developed Test
Related tests:
Labcorp® Plasma Focus™ is a highly actionable liquid biopsy test with a clear report that focuses on FDA-approved and guideline-driven biomarkers for patients with advanced solid cancers. Simplifies tumor genomic profiling process with a convenient blood draw that can reflex from tissue testing and delivers clear results. Delivers personalized results for patients’ unique tumors within 7-10 days.
Cancer:
Breast Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Melanoma, Non Small Cell Lung Cancer
Gene:
ALK (Anaplastic lymphoma kinase), CCND1 (Cyclin D1), EGFR (Epidermal growth factor receptor), FGFR2 (Fibroblast growth factor receptor 2), HER-2 (Human epidermal growth factor receptor 2), KIT (KIT proto-oncogene, receptor tyrosine kinase)
See More ...
ALK (Anaplastic lymphoma kinase), CCND1 (Cyclin D1), EGFR (Epidermal growth factor receptor), FGFR2 (Fibroblast growth factor receptor 2), HER-2 (Human epidermal growth factor receptor 2), KIT (KIT proto-oncogene, receptor tyrosine kinase), MET (MET proto-oncogene, receptor tyrosine kinase), MSI (Microsatellite instability), MYC (V-myc avian myelocytomatosis viral oncogene homolog), NTRK1 (Neurotrophic tyrosine kinase, receptor, type 1), PD-L1 (Programmed death ligand 1), RET (Ret Proto-Oncogene), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS)
Method:
Liquid biopsy
